Homepage| About Us| Catalog | Services
 

 

Favipiravir

Favipiravir is an antiviral medication that was initially developed to treat influenza.In February 2020, post the outbreak of Novel Coronavirus (COVID-19), Favipiravir was studied in China and several other countries as an experimental treatment of COVID-19. Clearsynth is helping your research by providing you number of potential compounds in the worldwide to fight against COVID 19. Favipiravir and its related reference standards are now available with Clearsynth.

Yes, I need more info !

NOW AVAILABLE

Image

Stable Isotope

CAS Number : CS-O-35654

CAT Number : 259793-96-9 (Unlabeled)



GET QUOTE

 

Image

Stable Isotope

CAS Number : CS-O-35629

CAT Number : 259793-96-9 (Unlabeled)



GET QUOTE

 

Image

Impurity

CAS Number : 356783-49-8

CAT Number : CS-P-08452



GET QUOTE

 

Image

Impurity

CAS Number : 6863-74-7

CAT Number : CS-T-72743



GET QUOTE

 

ALSO AVAILABLE

 

Favipiravir Impurity 11
CAT No: CS-P-08459
CAS: 440124-25-4


Get Quote


Favipiravir Impurity 9
CAT No: CS-P-08457
CAS: 1079990-21-8


Get Quote


6-Fluoro-pyrazine-2-carbonitrile
CAT No: CS-ZJ-18124
CAS: 356783-46-5


Get Quote


5-Fluoro-1H-pyrazin-2-one
CAT No: CS-ZJ-06717
CAS: 33870-92-7


Get Quote


6-chloro-3-hydroxypyrazine-2-carboxamide
CAT No: CS-ZE-24720
CAS: 259793-90-3


Get Quote


3,4-Dihydro-3-oxo-2-pyrazinecarboxamide
CAT No: CS-T-19268
CAS: 55321-99-8


Get Quote


6-Bromo-3-hydroxypyrazine-2-carboxamide
CAT No: CS-MM-50822
CAS: 259793-88-9


Get Quote


Favipiravir
CAT No: CS-O-13215
CAS: 259793-96-9


Get Quote


Check over more 7 reference compounds of Favipiravir are now available with Clearsynth

https://www.clearsynth.com/en/search?s=Favipiravir&t=5


Our Quality

 

 

(c) CLEARSYNTH